Literature DB >> 32632977

Complications from "Stem Cell Tourism" in Neurology.

Katherine Julian1,2, Nicholas Yuhasz1, Widjan Rai1, Jose A Salerno1,3, Jaime Imitola1,2,4.   

Abstract

"Stem cell tourism," the practice of offering unproven cellular preparations to patients as approved therapy, is rising in neurology. Currently, the experiences of patients and reported complications from these procedures are unknown in the United States. We evaluate academic neurologists' experiences with stem cell tourism and assess perceived competency on discussing this topic with patients. We found a lack of neurologist preparedness to discuss stem cell therapies with patients and an alarming list of unreported complications from these unregulated procedures. We also identified an urgent need for neurologist education and the creation of a national registry for reporting patient complications resulting from experimental stem cell interventions. ANN NEUROL 2020;88:661-668.
© 2020 American Neurological Association.

Entities:  

Mesh:

Year:  2020        PMID: 32632977     DOI: 10.1002/ana.25842

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  6 in total

1.  Experimental Treatments for Spinal Cord Injury: What you Should Know.

Authors:  Vieri Failli; Naomi Kleitman; Daniel P Lammertse; Jane T C Hsieh; John D Steeves; James W Fawcett; Mark H Tuszynski; Armin Curt; Michael G Fehlings; James D Guest; Andrew R Blight
Journal:  Top Spinal Cord Inj Rehabil       Date:  2021

2.  Role of Physicians in Guiding Patients Away From Unproven Stem Cell Interventions.

Authors:  Kirstin R W Matthews; Omar Kawam; Keri Sprung; Emerson C Perin; Zubin Master
Journal:  Tex Heart Inst J       Date:  2022-03-01

Review 3.  International stem cell tourism: a critical literature review and evidence-based recommendations.

Authors:  Samantha Lyons; Shival Salgaonkar; Gerard T Flaherty
Journal:  Int Health       Date:  2022-03-02       Impact factor: 2.473

Review 4.  Bringing Advanced Therapy Medicinal Products (ATMPs) for Parkinson's Disease to the Clinic: The Investigator's Perspective.

Authors:  Roger A Barker; Emma V Cutting; Danielle M Daft
Journal:  J Parkinsons Dis       Date:  2021       Impact factor: 5.568

5.  ISSCR's Guidelines for Stem Cell Research and Clinical Translation: Supporting development of safe and efficacious stem cell-based interventions.

Authors:  Leigh Turner
Journal:  Stem Cell Reports       Date:  2021-05-27       Impact factor: 7.765

6.  Inclusivity and diversity: Integrating international perspectives on stem cell challenges and potential.

Authors:  Robin Fears; Hidenori Akutsu; Lara Theresa Alentajan-Aleta; Andrés Caicedo; Antonio Carlos Campos de Carvalho; Miodrag Čolić; Jillian Cornish; Giulio Cossu; Patrice Debré; Geoffrey Dierckxsens; Nagwa El-Badri; George Griffin; Patrick Chingo-Ho Hsieh; Maneesha S Inamdar; Pradeep Kumar; Consuelo Macias Abraham; Romaldas Maciulaitis; Mamun Al Mahtab; Fergal J O'Brien; Michael Sean Pepper; Volker Ter Meulen
Journal:  Stem Cell Reports       Date:  2021-07-29       Impact factor: 7.765

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.